Loading clinical trials...
Loading clinical trials...
Rapamycin as Treatment for ADPKD: The Role of Biomarkers in Predicting a Response to Therapy
Conditions
Interventions
Rapamycin
Standard of Care-Placebo
Locations
1
United States
Yale Center for Clinical Investigation
New Haven, Connecticut, United States
Start Date
June 1, 2009
Primary Completion Date
July 1, 2010
Completion Date
July 1, 2010
Last Updated
April 14, 2014
NCT07454174
NCT06065852
NCT03901521
NCT06594367
NCT06289998
NCT05190744
Lead Sponsor
Yale University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions